awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38100790-5C97830E-38F8-4FBB-8960-57C2764BF913
Q38100790-5C97830E-38F8-4FBB-8960-57C2764BF913
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38100790-5C97830E-38F8-4FBB-8960-57C2764BF913
Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for clinicians.
P2860
Q38100790-5C97830E-38F8-4FBB-8960-57C2764BF913
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38100790-5C97830E-38F8-4FBB-8960-57C2764BF913
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d28dc7b6981ebfd3a838d80f6a5953a6d1b78b7
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.